Compare TKR & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TKR | ACLX |
|---|---|---|
| Founded | 1899 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.2B |
| IPO Year | N/A | 2022 |
| Metric | TKR | ACLX |
|---|---|---|
| Price | $86.68 | $72.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | $82.70 | ★ $115.71 |
| AVG Volume (30 Days) | 695.5K | ★ 1.4M |
| Earning Date | 10-29-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.23 | N/A |
| Revenue | ★ $4,544,400,000.00 | $35,898,000.00 |
| Revenue This Year | $0.39 | N/A |
| Revenue Next Year | $3.27 | $302.49 |
| P/E Ratio | $20.57 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $56.20 | $47.86 |
| 52 Week High | $89.21 | $94.07 |
| Indicator | TKR | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 69.83 | 40.25 |
| Support Level | $79.57 | $68.64 |
| Resistance Level | $89.21 | $73.98 |
| Average True Range (ATR) | 2.08 | 5.77 |
| MACD | 0.78 | -0.14 |
| Stochastic Oscillator | 83.95 | 21.95 |
The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The Company sells products and services to customers in the following market sectors: industrial distribution, renewable energy, automation, automotive original equipment (OE), agriculture/turf, rail, aerospace, auto/truck aftermarket, construction, etc. The company has two reportable segment: The Engineered Bearings portfolio features bearings with precision tolerances, proprietary internal geometries and quality materials. The Industrial Motion portfolio features products such as drives, breathers, seals, automatic lubrication systems, linear motion products, chain, belts, couplings, etc. Key revenue is generated from Engineered Bearings.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.